Search Results
Mark W. Bellomy
Partner
Mark Bellomy is a partner in Wilson Sonsini Goodrich & Rosati’s Boston office, where he is a member of the technology transactions practice. Mark advises numerous domestic and international public and private biopharmaceutical, medtech, digital health, medical device, and life sciences companies on all of the transactions related to the discovery, development, supply, and commercialization of their products, technologies, and services. He counsels clients with respect to structuring and negotiating a wide range of arrangements designed to maximize the value of their businesses.
Miranda Biven
Partner
Miranda advises life sciences clients in partnering and licensing arrangements, M&A, and other transactions.
Nellie J. Brutocao
Partner
Nellie Brutocao is a partner in the technology transactions practice at Wilson Sonsini Goodrich & Rosati. Her practice focuses on the life sciences industry, representing public and private companies in intellectual property and commercial transactions, including strategic alliances, research and development collaborations, technology licenses and acquisitions, supply, distribution and manufacturing agreements, sponsored research agreements, clinical trials arrangements, material transfer agreements, and co-promotion arrangements. She has also represented life sciences companies in complex commercial and patent disputes, including Hatch-Waxman litigation.
Ian B. Edvalson
Partner
Ian advises life sciences clients in strategic alliances, agreements, arrangements, collaborations, and joint ventures.
Farah B. Gerdes
Partner
Farah focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in complex collaboration and partnering transactions.
Tina Hanson
Partner
Kristina Hanson is a partner in the San Francisco office of Wilson Sonsini Goodrich & Rosati. Her practice primarily focuses on intellectual property litigation, with an emphasis on pharmaceutical patent matters arising under the Hatch-Waxman Act. She has represented clients in a variety of pharmaceutical matters, from pre-trial strategy counseling through appeals.
Andrew D. Hoffman
Partner
Andrew’s practice focuses on corporate and securities work for companies at all stages of growth, as well as for financial institutions, venture capital firms, and other investors.
Norm Hovijitra
Partner
Dr. Norm Hovijitra is a partner in the technology transactions practice at Wilson Sonsini Goodrich & Rosati. He advises emerging and established companies in the life sciences industry on legal and business issues associated with the development, manufacture, and commercialization of their products and technologies, including matters relating to intellectual property strategy and patents.
Alex Key
Partner
Alex focuses on representing clients in the biotechnology, pharmaceutical, medical device, diagnostic, and digital health industries.
Lou Lieto
Partner
Dr. Lieto focuses on patent law-related matters for clients in the life sciences industry.
Matthew R. Reed
Partner
Matt practices in the areas of technology-focused international and domestic arbitration and intellectual property litigation, including patent litigation in U.S. district courts and the ITC, and trade secret disputes in state and federal court.
Seth C. Silber
Partner
Seth advises pharmaceutical and healthcare companies on antitrust matters, including patent settlements, mergers and acquisitions, and anticompetitive conduct.
Maya Skubatch
Partner
Maya focuses on strategic patent counseling for healthcare and other technology-driven companies.
Marina C. Tsatalis
Partner
Marina advises and represents the world’s leading technology, communications, pharmaceutical, and life sciences companies in significant trade secret and employee mobility matters.
Stuart A. Williams
Partner
Stuart focuses on the firm’s global generics practice, working closely with many different practice areas across the firm.